CME Group (NASDAQ:CME) Price Target Increased to $216.00 by Analysts at Bank of America

CME Group (NASDAQ:CME) had its price target raised by equities researchers at Bank of America from $209.00 to $216.00 in a research note issued on Thursday, Benzinga reports. The firm currently has a “neutral” rating on the financial services provider’s stock. Bank of America‘s price target would indicate a potential upside of 1.26% from the company’s previous close.

A number of other research analysts have also weighed in on CME. Barclays boosted their target price on shares of CME Group from $225.00 to $226.00 and gave the stock an “equal weight” rating in a research report on Monday, April 8th. Argus raised their target price on CME Group from $225.00 to $245.00 and gave the company a “buy” rating in a report on Wednesday, March 6th. Rosenblatt Securities reaffirmed a “sell” rating and issued a $187.00 price target (up from $185.00) on shares of CME Group in a research report on Thursday. Deutsche Bank Aktiengesellschaft reaffirmed a “hold” rating and set a $210.00 target price (down previously from $235.00) on shares of CME Group in a research report on Friday, April 5th. Finally, Morgan Stanley raised their price target on shares of CME Group from $222.00 to $225.00 and gave the stock an “equal weight” rating in a research report on Tuesday, April 9th. Two analysts have rated the stock with a sell rating, seven have issued a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat.com, CME Group presently has an average rating of “Hold” and an average target price of $217.60.

CME Group Trading Up 0.3 %

Shares of NASDAQ:CME traded up $0.72 during trading on Thursday, reaching $213.31. 864,902 shares of the stock were exchanged, compared to its average volume of 1,778,687. The firm has a market cap of $76.79 billion, a price-to-earnings ratio of 24.04, a price-to-earnings-growth ratio of 6.09 and a beta of 0.49. The firm’s 50-day moving average price is $214.73 and its 200 day moving average price is $211.93. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.02 and a current ratio of 1.02. CME Group has a 12-month low of $175.73 and a 12-month high of $223.80.

CME Group (NASDAQ:CME) last announced its quarterly earnings results on Wednesday, April 24th. The financial services provider reported $2.50 earnings per share for the quarter, topping analysts’ consensus estimates of $2.44 by $0.06. CME Group had a return on equity of 12.32% and a net margin of 57.83%. The business had revenue of $1.49 billion for the quarter, compared to analysts’ expectations of $1.48 billion. During the same period in the prior year, the firm earned $2.42 EPS. The business’s quarterly revenue was up 3.2% on a year-over-year basis. On average, sell-side analysts anticipate that CME Group will post 9.58 earnings per share for the current fiscal year.

Institutional Investors Weigh In On CME Group

A number of institutional investors have recently made changes to their positions in the stock. B. Riley Wealth Advisors Inc. increased its position in shares of CME Group by 1.3% in the 4th quarter. B. Riley Wealth Advisors Inc. now owns 3,625 shares of the financial services provider’s stock valued at $782,000 after buying an additional 48 shares in the last quarter. Capital Advisors Ltd. LLC grew its position in shares of CME Group by 4.3% in the 1st quarter. Capital Advisors Ltd. LLC now owns 1,160 shares of the financial services provider’s stock valued at $250,000 after purchasing an additional 48 shares during the period. Lantz Financial LLC increased its stake in CME Group by 1.1% during the 1st quarter. Lantz Financial LLC now owns 4,561 shares of the financial services provider’s stock worth $982,000 after purchasing an additional 49 shares in the last quarter. Transcend Capital Advisors LLC increased its stake in CME Group by 1.7% during the 4th quarter. Transcend Capital Advisors LLC now owns 2,995 shares of the financial services provider’s stock worth $631,000 after purchasing an additional 50 shares in the last quarter. Finally, Jaffetilchin Investment Partners LLC lifted its stake in CME Group by 1.7% in the third quarter. Jaffetilchin Investment Partners LLC now owns 3,022 shares of the financial services provider’s stock valued at $605,000 after buying an additional 51 shares in the last quarter. 87.75% of the stock is owned by institutional investors and hedge funds.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.